Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.800
+0.320 (12.90%)
At close: Jun 20, 2025, 4:00 PM
2.880
+0.080 (2.86%)
After-hours: Jun 20, 2025, 7:56 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $16.49 million as of June 20, 2025. Its market cap has increased by 135.47% in one year.
Market Cap
16.49M
Enterprise Value
15.55M
1-Year Change
135.47%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $16.49M, a decrease of -84.07%. That is a compound annual growth rate of -33.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 16.49M | -34.73% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |